Skip to main content
UNION KOREA PHARM CO.,Ltd logo

UNION KOREA PHARM CO.,Ltd — Investor Relations & Filings

Ticker · 080720 ISIN · KR7080720006 KO Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2025-08-01 Declaration of Voting R…
Country KR South Korea
Listing KO 080720

About UNION KOREA PHARM CO.,Ltd

https://ukp.co.kr/

UNION KOREA PHARM CO.,Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of prescription drugs. The company produces a range of specialty medicines in various formulations, including solid dosage forms, liquid injections, and powders. Its product portfolio addresses therapeutic areas such as neoplasms, immune system diseases, anti-inflammatory analgesics, antibiotics, and skeletal muscle relaxants. The company emphasizes strict quality control throughout the entire production cycle, from raw materials to shipping, to ensure its products meet Good Manufacturing Practice (GMP) standards. It operates in both domestic and international markets.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and provides the outcome of a shareholder vote held on 2025-08-01, specifically noting that the agenda item (amendment of articles of incorporation) was approved. This falls directly under the definition of a Declaration of Voting Results.
2025-08-01 Korean
[기재정정]주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of Bonds with Warrants (신주인수권부사채 발행결정). It details the terms of the bond issuance, including interest rates, maturity dates, and conversion options. This type of filing is a standard regulatory disclosure in the Korean market for capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2025-07-25 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a regulatory filing from Korea Union Pharmaceutical regarding a 'Resolution to Convene a General Meeting of Shareholders' (specifically an Extraordinary General Meeting). It details a correction (amendment) to the previously announced date of the meeting. Since this document is a formal regulatory notice regarding the scheduling and procedural details of a shareholder meeting, it falls under the category of Proxy Solicitation & Information Statement (PSI), as these filings are used to inform shareholders of meeting logistics and agenda items.
2025-07-16 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) issued by Korea Union Pharm. It details the agenda for an upcoming meeting, specifically focusing on amendments to the Articles of Incorporation (정관 변경). It includes management information, board activity reports, and specific voting items. This document is a standard proxy solicitation material sent to shareholders to inform them of the meeting details and request their participation/votes, which fits the definition of a Proxy Solicitation & Information Statement.
2025-07-16 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a formal filing submitted to the Financial Services Commission/Korea Exchange. It details the solicitation of proxies for an upcoming shareholder meeting, including specific agenda items such as amendments to the articles of incorporation. This document type is explicitly defined as 'Proxy Solicitation & Information Statement' (PSI) in the provided classification schema.
2025-07-16 Korean
불성실공시법인지정예고 (공시불이행 3건)
Regulatory Filings Classification · 100% confidence The document is a formal notice from the Korea Exchange (KRX) regarding the 'Designation of Unfaithful Disclosure Corporation' (불성실공시법인지정예고) for Korea Union Pharm. It details specific instances of non-compliance with disclosure regulations (failure to disclose changes in major shareholders, etc.). Since this is a regulatory notice regarding compliance and potential penalties, it falls under the 'Regulatory Filings' category as it does not fit into specific financial reporting or corporate action categories.
2025-07-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.